Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 25, 2013
Clariant, a world leader in specialty chemicals, represented by its Masterbatches Business Unit with business segments Healthcare Packaging and Masterbatches for medical applications, will exhibit and present at InnoPack 2013, a co-event at CPhI in ...
read more
Thursday, October 03, 2013
AMRI today announced that its wholly owned subsidiary, Albany Molecular Research (UK) Ltd., located in Holywell, Wales, United Kingdom, has been awarded a seven-year contract for the development and manufacture of an active ingredient under clinical...
read more
Tuesday, October 22, 2013
Global pharmaceutical chemistry leader Cambridge Major Laboratories Europe, B.V. (CML-Europe) is pleased to announce the successful completion of its first Food and Drug Administration inspection. The inspection included a pre-approval inspection and...
read more
Thursday, October 31, 2013
Quality by Design (QbD) and its systematic approach to development begins with a predefined objective and emphasizes sound science and quality risk principles as an integral part of product development and process control implementation, and can help...
read more
Monday, November 04, 2013
The CPhI Pharma Awards 2013 winners were announced live at the awards ceremony- day one at CPhI Worldwide. Honouring outstanding developments from some key industry players, the awards highlighted ever-advancing market innovations, fundamental to ...
read more
Monday, November 04, 2013
Cambridge Major Laboratories, Inc. (“CML”), a global leader in pharmaceutical API development and manufacturing, and AAIPharma Services, Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and ...
read more
Wednesday, November 27, 2013
CPhI Worldwide, organised by UBM Live, celebrates the closing of its most successful show to date with pre-audit figures estimating more than 34,000 attendees and 2,200 exhibitors. Held in Frankfurt, the show hosted senior-level decision makers and ...
read more
Wednesday, December 04, 2013
AAIPharma Services, Corp. (“AAI”), a
leading global provider of pharmaceutical analytical testing, product development and
manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in
pharmaceutical API development and...
read more
Wednesday, December 04, 2013
Timothy C. Tyson, Chairman of Aptuit LLC, announced today the appointment of Jonathan Goldman, MD as Chief Executive Officer (CEO), completing the company’s senior management leadership team.
read more
Friday, December 13, 2013
Almac‘s Enzyme Research and Development team have been recognised at The Irish Laboratory Awards by winning “Laboratory Team of the Year.”
read more
Friday, December 20, 2013
Following a successful inspection by the German health authorities in July 2013 ChemCon received the approval required to manufacture semi-solid pharmaceuticals (gels and creams for topical therapy) for human use. This was an important step for the ...
read more
Tuesday, January 28, 2014
CPhI, part of UBM Live, has announced the appointment of Chris Kilbee to the role of Group Director of the UBM Pharma Portfolio. Central to the role is responsibility for the strategic development and delivery of market leading event brands CPhI, ...
read more
Tuesday, January 28, 2014
CPhI Worldwide, organised by UBM Live, announces the launch of the CPhI Pharma InsightsUSA market report. A joint venture with InformEx, the report will provide European perspectives on the accessibility, growth and export market in the USA and is ...
read more
Tuesday, January 28, 2014
Johnson Matthey Catalysis and Chiral Technologies (JMCCT), a business unit of Johnson Matthey Fine Chemical Division (LSE: JMAT), has announced an expansion to its proprietary tethered catalyst technology, and is now offering multi-kilogram ...
read more
Tuesday, February 18, 2014
Cedarburg Hauser Pharmaceuticals (CHP), an experienced contract
development and manufacturing organization (CDMO) specializing in small molecule APIs, has
announced the hire Alex Tretyakov, Ph.D. as its Director of Process Development.
read more